Name: Preclinical Safety
Brand: Novartis
Availability: OnlineOnly
Rating: 5.0 (5 reviews)

Back to Preclinical Safety

Learner Reviews & Feedback for Preclinical Safety by Novartis

5.0

stars

22 ratings

About the Course

Patient safety is of paramount importance for any drug discovery program.  This course looks at some of the lessons learned which have influenced how promising molecules are currently evaluated for safety risks.  In vitro and in vivo toxicology and safety studies are discussed, why they are performed, and how the data they provide guide a safety risk assessment, including determining a therapeutic index or safety window for a drug.  Finally, the course will look at how safety data guide human dose selection, and some of the studies performed during clinical development. Target audience: This course is suitable for life scientists, clinicians, and individuals from fields that support drug discovery (e.g., patents, finance, licensing, etc.) interested in learning more about the pharmaceutical/biotechnology sector. Advanced undergraduate coursework or practical familiarity/working knowledge in biological sciences and organic chemistry is recommended....

Top reviews

Aug 4, 2024

The Course is very useful to those interested in understanding the principles of Pre-clinical Safety. I completed the course quickly in three sittings due to my prior exposure to this area.

Aug 7, 2024

excellent overview, very concise yet full of practical and useful information

Filter by:

1 - 5 of 5 Reviews for Preclinical Safety

By David M

•

May 8, 2025

I think Novartis did a spectacular job adding these course to Coursera. These courses provide anyone with information that is crucial to pharmaceutical industry and drug development. This course on Preclinical Safety is worth taking.

By Panduranga R V

•

Aug 4, 2024

The Course is very useful to those interested in understanding the principles of Pre-clinical Safety. I completed the course quickly in three sittings due to my prior exposure to this area.